BCM
DXCM icon

Brooktree Capital Management’s DexCom DXCM Stock Holding History

Brooktree Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.44M Buy
51,061
+783
+2% +$52.2K 2.24% 13
2026
Q1 		$3.16M Buy
50,278
+5,621
+13% +$391K 2.5% 12
2025
Q4 		$2.96M Buy
44,657
+2,777
+7% +$180K 1.97% 12
2025
Q3 		$2.82M Buy
41,880
+12,635
+43% +$1,000K 1.79% 14
2025
Q2 		$2.55M Buy
29,245
+13,713
+88% +$1.07M 1.67% 13
2025
Q1 		$1.06M Buy
15,532
+1,896
+14% +$155K 0.8% 20
2024
Q4 		$1.06M Buy
13,636
+3,453
+34% +$256K 0.79% 20
2024
Q3 		$683K Buy
+10,183
New +$836K 0.55% 22

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brooktree Capital Management's DXCM Position: Q2 2026 in Review

Brooktree Capital Management increased its DexCom (DXCM) stake by 1.6% in Q2 2026, buying an estimated $52.2K and bringing the position to 51,061 shares worth $3.44M. The position accounts for 2.24% of the portfolio, ranked #13.

Brooktree Capital Management first reported a position in DXCM in Q3 2024 and has held it in 8 quarters since. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Brooktree Capital Management held 51,061 shares of DexCom worth $3.44M as of Q2 2026.
  • Brooktree Capital Management bought 783 DexCom shares in Q2 2026, an estimated $52.2K.
  • DexCom made up 2.24% of Brooktree Capital Management's portfolio in Q2 2026, its #13 holding.
  • Brooktree Capital Management first reported a position in DexCom in Q3 2024 and has held it in 8 quarters since.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Brooktree Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.